The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy
Advanced Science · 2024
DOI: 10.1002/advs.202400952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhiqiang Hu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Immunotherapy, Protein Serine-Threonine Kinases, Protozoan Proteins, Toxoplasma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Toxoplasma gondii ( T. gondii )‐associated polymorphic effector proteins are crucial in parasite development and regulating host anti‐ T. gondii immune responses. However, the mechanism remains obscure. Here, it is shown that Toxoplasma effector dense granules 4 (GRA4) restricts host IFN‐I activation. Infection with Δ gra4 mutant T. gondii strain induces stronger IFN‐I responses and poses a severe threat to host health. Mechanistically, GRA4 binds to phosphorylated TBK1 to promote TRIM27‐catalyzed K48‐ubiquitination at Lys251/Lys372 residues, which enhances its recognition by autophagy receptor p62, ultimately leading to TBK1 autophagic degradation. Furthermore, an avirulent Δ gra4 strain (ME49Δ ompdc / gra4 ) is constructed for tumor immunotherapy due to its ability to enhance IFN‐I production. Earlier vaccination with ME49Δ ompdc / gra4 confers complete host resistance to the tumor compared with the classical ME49Δ ompdc treatment. Notably, ME49Δ ompdc / gra4 vaccination induces a specific CD64 + MAR‐1 + CD11b + dendritic cell subset, thereby enhancing T cell anti‐tumor responses. Overall, these findings identify the negative role of T. gondii GRA4 in modulating host IFN‐I signaling and suggest that GRA4 can be a potential target for the development of T. gondii vaccines and tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310029, China.
- State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China.
- State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
- Department of Joint Surgery, the Fifth Affiliated Hospital of Southern Medical University, Guangzhou, 510900, China.
- Yue Bei People's Hospital Postdoctoral Innovation Practice Base, Southern Medical University, Guangzhou, 510515, China.
ORCID-Profile: Xiao Yu
Förderung
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Hu, Z., Zhang, Y., Xie, Y., Yang, J., Tang, H., Fan, B., Zeng, K., Han, Z., Lu, J., Jiang, H., Peng, W., Li, H., Chen, H., Wu, S., Shen, B., Lun, Z. R., & Yu, X. (2024). The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202400952
Vancouver
Hu Z, Zhang Y, Xie Y, Yang J, Tang H, Fan B, et al. The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy. Advanced Science. 2024. doi:10.1002/advs.202400952
BibTeX
@article{Hu2024,
author = {Hu, Zhiqiang and Zhang, Yufen and Xie, Yingchao and Yang, Jianwu and Tang, Haotian and Fan, Bolin and Zeng, Ke and Han, Zhongxin and Lu, Jiansen and Jiang, Huaji and Peng, Wenqiang and Li, Hongyu and Chen, Huadan and Wu, Sha and Shen, Bang and Lun, Zhao-Rong and Yu, Xiao},
title = {The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202400952}
}
EUVIMED